IL6 and chronic kidney disease: In particular, neurodegenerative mechanisms may be associated with the low efficiency of elimination of metabolic waste or uremic toxins, including uric acid, p-cresyl sulfate, indoxyl sulfate, tumor necrosis factor-α, interleukin-1β and interleukin-6 in patients with CKD (19).